Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth (Status and Outlook) 2026-2032
The global N-Acetylglutamate Synthetase Deficiency (NAGSD) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
N-Acetylglutamate Synthase Deficiency (NAGS Deficiency) is a rare inherited metabolic disorder and a member of the urea cycle disorders (UCDs). The urea cycle converts toxic ammonia in the body into non-toxic urea, which is excreted from the body through the kidneys.
United States market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key N-Acetylglutamate Synthetase Deficiency (NAGSD) players cover Recordati Rare Diseases, Grand Pharmaceutical Group, Sovereign Medical, Lee's Pharmaceuticals, Medunik, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Forecast” looks at past sales and reviews total world N-Acetylglutamate Synthetase Deficiency (NAGSD) sales in 2025, providing a comprehensive analysis by region and market sector of projected N-Acetylglutamate Synthetase Deficiency (NAGSD) sales for 2026 through 2032. With N-Acetylglutamate Synthetase Deficiency (NAGSD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world N-Acetylglutamate Synthetase Deficiency (NAGSD) industry.
This Insight Report provides a comprehensive analysis of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on N-Acetylglutamate Synthetase Deficiency (NAGSD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global N-Acetylglutamate Synthetase Deficiency (NAGSD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for N-Acetylglutamate Synthetase Deficiency (NAGSD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global N-Acetylglutamate Synthetase Deficiency (NAGSD).
This report presents a comprehensive overview, market shares, and growth opportunities of N-Acetylglutamate Synthetase Deficiency (NAGSD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
N-Acetylglutamate Synthase Deficiency (NAGS Deficiency) is a rare inherited metabolic disorder and a member of the urea cycle disorders (UCDs). The urea cycle converts toxic ammonia in the body into non-toxic urea, which is excreted from the body through the kidneys.
United States market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key N-Acetylglutamate Synthetase Deficiency (NAGSD) players cover Recordati Rare Diseases, Grand Pharmaceutical Group, Sovereign Medical, Lee's Pharmaceuticals, Medunik, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Forecast” looks at past sales and reviews total world N-Acetylglutamate Synthetase Deficiency (NAGSD) sales in 2025, providing a comprehensive analysis by region and market sector of projected N-Acetylglutamate Synthetase Deficiency (NAGSD) sales for 2026 through 2032. With N-Acetylglutamate Synthetase Deficiency (NAGSD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world N-Acetylglutamate Synthetase Deficiency (NAGSD) industry.
This Insight Report provides a comprehensive analysis of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on N-Acetylglutamate Synthetase Deficiency (NAGSD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global N-Acetylglutamate Synthetase Deficiency (NAGSD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for N-Acetylglutamate Synthetase Deficiency (NAGSD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global N-Acetylglutamate Synthetase Deficiency (NAGSD).
This report presents a comprehensive overview, market shares, and growth opportunities of N-Acetylglutamate Synthetase Deficiency (NAGSD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Original Drug
- Generic Drug
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recordati Rare Diseases
- Grand Pharmaceutical Group
- Sovereign Medical
- Lee's Pharmaceuticals
- Medunik
- Acer Therapeutics
- Sigmapharm Laboratories
- Amgen
- Immedica
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
2.1.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for N-Acetylglutamate Synthetase Deficiency (NAGSD) by Country/Region (2021, 2025 & 2032)
2.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
2.2.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
2.3.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
3 N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) MARKET SIZE BY PLAYER
3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Player
3.1.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Player (2021-2026)
3.1.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Player (2021-2026)
3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) BY REGION
4.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026)
4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Annual Revenue by Country/Region (2021-2026)
4.3 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
4.4 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
4.5 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
4.6 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
5.2 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
5.3 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026)
6.2 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
6.3 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
7.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
7.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) by Region (2021-2026)
8.2 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
8.3 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) MARKET FORECAST
10.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.1.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.1.2 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.1.3 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.1.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.1.5 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Country (2027-2032)
10.2.1 United States Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2.2 Canada Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2.3 Mexico Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2.4 Brazil Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.3.1 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Forecast
10.3.2 Japan Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.3 Korea Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.4 Southeast Asia Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.5 India Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.6 Australia Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Country (2027-2032)
10.4.1 Germany Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.2 France Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.3 UK Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.4 Italy Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.5 Russia Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.5.1 Egypt Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5.2 South Africa Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5.3 Israel Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5.4 Turkey Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.6 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Type (2027-2032)
10.7 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recordati Rare Diseases
11.1.1 Recordati Rare Diseases Company Information
11.1.2 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.1.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Recordati Rare Diseases Main Business Overview
11.1.5 Recordati Rare Diseases Latest Developments
11.2 Grand Pharmaceutical Group
11.2.1 Grand Pharmaceutical Group Company Information
11.2.2 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.2.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Grand Pharmaceutical Group Main Business Overview
11.2.5 Grand Pharmaceutical Group Latest Developments
11.3 Sovereign Medical
11.3.1 Sovereign Medical Company Information
11.3.2 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sovereign Medical Main Business Overview
11.3.5 Sovereign Medical Latest Developments
11.4 Lee's Pharmaceuticals
11.4.1 Lee's Pharmaceuticals Company Information
11.4.2 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.4.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lee's Pharmaceuticals Main Business Overview
11.4.5 Lee's Pharmaceuticals Latest Developments
11.5 Medunik
11.5.1 Medunik Company Information
11.5.2 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.5.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Medunik Main Business Overview
11.5.5 Medunik Latest Developments
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Information
11.6.2 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.6.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Acer Therapeutics Main Business Overview
11.6.5 Acer Therapeutics Latest Developments
11.7 Sigmapharm Laboratories
11.7.1 Sigmapharm Laboratories Company Information
11.7.2 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.7.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sigmapharm Laboratories Main Business Overview
11.7.5 Sigmapharm Laboratories Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 Immedica
11.9.1 Immedica Company Information
11.9.2 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.9.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Immedica Main Business Overview
11.9.5 Immedica Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
2.1.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for N-Acetylglutamate Synthetase Deficiency (NAGSD) by Country/Region (2021, 2025 & 2032)
2.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
2.2.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
2.3.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
3 N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) MARKET SIZE BY PLAYER
3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Player
3.1.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Player (2021-2026)
3.1.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Player (2021-2026)
3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) BY REGION
4.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026)
4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Annual Revenue by Country/Region (2021-2026)
4.3 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
4.4 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
4.5 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
4.6 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
5.2 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
5.3 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026)
6.2 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
6.3 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
7.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
7.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) by Region (2021-2026)
8.2 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
8.3 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) MARKET FORECAST
10.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.1.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.1.2 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.1.3 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.1.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.1.5 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2 Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Country (2027-2032)
10.2.1 United States Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2.2 Canada Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2.3 Mexico Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.2.4 Brazil Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3 APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.3.1 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Forecast
10.3.2 Japan Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.3 Korea Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.4 Southeast Asia Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.5 India Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.3.6 Australia Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Country (2027-2032)
10.4.1 Germany Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.2 France Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.3 UK Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.4 Italy Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.4.5 Russia Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Region (2027-2032)
10.5.1 Egypt Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5.2 South Africa Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5.3 Israel Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.5.4 Turkey Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
10.6 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Type (2027-2032)
10.7 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Recordati Rare Diseases
11.1.1 Recordati Rare Diseases Company Information
11.1.2 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.1.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Recordati Rare Diseases Main Business Overview
11.1.5 Recordati Rare Diseases Latest Developments
11.2 Grand Pharmaceutical Group
11.2.1 Grand Pharmaceutical Group Company Information
11.2.2 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.2.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Grand Pharmaceutical Group Main Business Overview
11.2.5 Grand Pharmaceutical Group Latest Developments
11.3 Sovereign Medical
11.3.1 Sovereign Medical Company Information
11.3.2 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sovereign Medical Main Business Overview
11.3.5 Sovereign Medical Latest Developments
11.4 Lee's Pharmaceuticals
11.4.1 Lee's Pharmaceuticals Company Information
11.4.2 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.4.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lee's Pharmaceuticals Main Business Overview
11.4.5 Lee's Pharmaceuticals Latest Developments
11.5 Medunik
11.5.1 Medunik Company Information
11.5.2 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.5.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Medunik Main Business Overview
11.5.5 Medunik Latest Developments
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Information
11.6.2 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.6.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Acer Therapeutics Main Business Overview
11.6.5 Acer Therapeutics Latest Developments
11.7 Sigmapharm Laboratories
11.7.1 Sigmapharm Laboratories Company Information
11.7.2 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.7.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sigmapharm Laboratories Main Business Overview
11.7.5 Sigmapharm Laboratories Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 Immedica
11.9.1 Immedica Company Information
11.9.2 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
11.9.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Immedica Main Business Overview
11.9.5 Immedica Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. N-Acetylglutamate Synthetase Deficiency (NAGSD) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Table 8. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 10. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Table 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Player (2021-2026) & ($ millions)
Table 12. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Player (2021-2026)
Table 13. N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Players Head office and Products Offered
Table 14. N-Acetylglutamate Synthetase Deficiency (NAGSD) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & ($ millions)
Table 18. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Table 19. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Country (2021-2026)
Table 23. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Table 25. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Table 27. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Table 29. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Country (2021-2026)
Table 33. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of N-Acetylglutamate Synthetase Deficiency (NAGSD)
Table 39. Key Market Challenges & Risks of N-Acetylglutamate Synthetase Deficiency (NAGSD)
Table 40. Key Industry Trends of N-Acetylglutamate Synthetase Deficiency (NAGSD)
Table 41. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Recordati Rare Diseases Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 46. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 47. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Recordati Rare Diseases Main Business
Table 49. Recordati Rare Diseases Latest Developments
Table 50. Grand Pharmaceutical Group Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 51. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 52. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Grand Pharmaceutical Group Main Business
Table 54. Grand Pharmaceutical Group Latest Developments
Table 55. Sovereign Medical Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 56. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 57. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Sovereign Medical Main Business
Table 59. Sovereign Medical Latest Developments
Table 60. Lee's Pharmaceuticals Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 61. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 62. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Lee's Pharmaceuticals Main Business
Table 64. Lee's Pharmaceuticals Latest Developments
Table 65. Medunik Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 66. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 67. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Medunik Main Business
Table 69. Medunik Latest Developments
Table 70. Acer Therapeutics Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 71. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 72. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Acer Therapeutics Main Business
Table 74. Acer Therapeutics Latest Developments
Table 75. Sigmapharm Laboratories Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 76. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 77. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Sigmapharm Laboratories Main Business
Table 79. Sigmapharm Laboratories Latest Developments
Table 80. Amgen Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 81. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 82. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85. Immedica Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 86. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 87. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Immedica Main Business
Table 89. Immedica Latest Developments
Table 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. N-Acetylglutamate Synthetase Deficiency (NAGSD) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Table 8. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 10. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Table 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Player (2021-2026) & ($ millions)
Table 12. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Player (2021-2026)
Table 13. N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Players Head office and Products Offered
Table 14. N-Acetylglutamate Synthetase Deficiency (NAGSD) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & ($ millions)
Table 18. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Table 19. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Country (2021-2026)
Table 23. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Table 25. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Table 27. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Table 29. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Country (2021-2026)
Table 33. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of N-Acetylglutamate Synthetase Deficiency (NAGSD)
Table 39. Key Market Challenges & Risks of N-Acetylglutamate Synthetase Deficiency (NAGSD)
Table 40. Key Industry Trends of N-Acetylglutamate Synthetase Deficiency (NAGSD)
Table 41. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Recordati Rare Diseases Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 46. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 47. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Recordati Rare Diseases Main Business
Table 49. Recordati Rare Diseases Latest Developments
Table 50. Grand Pharmaceutical Group Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 51. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 52. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Grand Pharmaceutical Group Main Business
Table 54. Grand Pharmaceutical Group Latest Developments
Table 55. Sovereign Medical Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 56. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 57. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Sovereign Medical Main Business
Table 59. Sovereign Medical Latest Developments
Table 60. Lee's Pharmaceuticals Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 61. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 62. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Lee's Pharmaceuticals Main Business
Table 64. Lee's Pharmaceuticals Latest Developments
Table 65. Medunik Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 66. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 67. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Medunik Main Business
Table 69. Medunik Latest Developments
Table 70. Acer Therapeutics Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 71. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 72. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Acer Therapeutics Main Business
Table 74. Acer Therapeutics Latest Developments
Table 75. Sigmapharm Laboratories Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 76. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 77. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Sigmapharm Laboratories Main Business
Table 79. Sigmapharm Laboratories Latest Developments
Table 80. Amgen Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 81. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 82. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85. Immedica Details, Company Type, N-Acetylglutamate Synthetase Deficiency (NAGSD) Area Served and Its Competitors
Table 86. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Offered
Table 87. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Immedica Main Business
Table 89. Immedica Latest Developments
LIST OF FIGURES
Figure 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. N-Acetylglutamate Synthetase Deficiency (NAGSD) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. N-Acetylglutamate Synthetase Deficiency (NAGSD) Sales Market Share by Country/Region (2025)
Figure 8. N-Acetylglutamate Synthetase Deficiency (NAGSD) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type in 2025
Figure 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) in Adults
Figure 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market: Adults (2021-2026) & ($ millions)
Figure 12. N-Acetylglutamate Synthetase Deficiency (NAGSD) in Children
Figure 13. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market: Children (2021-2026) & ($ millions)
Figure 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application in 2025
Figure 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Player in 2025
Figure 16. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Figure 17. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 18. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 19. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 21. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Value Market Share by Country in 2025
Figure 22. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region in 2025
Figure 27. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Figure 28. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Figure 29. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 33. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Country in 2025
Figure 36. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Figure 37. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Figure 38. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 39. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 40. UK N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Figure 46. Egypt N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 52. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 53. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 55. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 56. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 57. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 58. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 59. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 60. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 61. Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 63. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 64. Australia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 65. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 66. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 67. UK N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 68. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 69. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 70. Egypt N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 71. South Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 72. Israel N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 73. Turkey N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 74. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. N-Acetylglutamate Synthetase Deficiency (NAGSD) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. N-Acetylglutamate Synthetase Deficiency (NAGSD) Sales Market Share by Country/Region (2025)
Figure 8. N-Acetylglutamate Synthetase Deficiency (NAGSD) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type in 2025
Figure 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) in Adults
Figure 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market: Adults (2021-2026) & ($ millions)
Figure 12. N-Acetylglutamate Synthetase Deficiency (NAGSD) in Children
Figure 13. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market: Children (2021-2026) & ($ millions)
Figure 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application in 2025
Figure 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Player in 2025
Figure 16. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Figure 17. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 18. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 19. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2021-2026 ($ millions)
Figure 21. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Value Market Share by Country in 2025
Figure 22. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region in 2025
Figure 27. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Figure 28. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Figure 29. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 33. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Country in 2025
Figure 36. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Figure 37. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Figure 38. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 39. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 40. UK N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share by Application (2021-2026)
Figure 46. Egypt N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 52. APAC N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 53. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 55. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 56. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 57. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 58. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 59. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 60. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 61. Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 63. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 64. Australia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 65. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 66. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 67. UK N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 68. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 69. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 70. Egypt N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 71. South Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 72. Israel N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 73. Turkey N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
Figure 74. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size 2027-2032 ($ millions)
